JAGUAR HEALTH, INC. Selling and Marketing Expense
JAGUAR HEALTH, INC. (JAGX) reported Selling and Marketing Expense of $5.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-19
- JAGUAR HEALTH, INC. selling and marketing expense for the quarter ending 2026-06-30 was $5.00K, a 99.80% decline year-over-year.
- JAGUAR HEALTH, INC. selling and marketing expense for the quarter ending 2026-03-31 was $896.00K, a 64.06% decline year-over-year.
- JAGUAR HEALTH, INC. selling and marketing expense for the quarter ending 2025-12-31 was $2.28M, a 16.10% decline year-over-year.
- JAGUAR HEALTH, INC. selling and marketing expense for the quarter ending 2025-09-30 was $2.00M, a 0.65% decline year-over-year.
- JAGUAR HEALTH, INC. selling and marketing expense for fiscal 2025 was $9.23M, a 20.06% increase from fiscal 2024.
- JAGUAR HEALTH, INC. selling and marketing expense for fiscal 2024 was $7.69M, a 19.07% increase from fiscal 2023.
- JAGUAR HEALTH, INC. selling and marketing expense for fiscal 2023 was $6.46M, a 26.90% decline from fiscal 2022.
- JAGUAR HEALTH, INC. selling and marketing expense for fiscal 2022 was $8.84M, a 0.64% decline from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00K 10-Q · filed 2026-08-19 | $901.00K 10-Q · filed 2026-08-19 | $3.18M derived: sum of 3 quarters · filed 2026-08-19 | $5.18M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $896.00K 10-Q · filed 2026-05-20 | $3.17M derived: sum of 2 quarters · filed 2026-05-20 | $5.17M derived: sum of 3 quarters · filed 2026-05-20 | $7.64M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $4.28M derived: sum of 2 quarters · filed 2026-04-07 | $6.74M derived: sum of 3 quarters · filed 2026-08-19 | $9.23M 10-K · filed 2026-04-07 | ||||
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-14 | $4.46M derived: sum of 2 quarters · filed 2026-08-19 | $6.96M 10-Q · filed 2025-11-14 | $9.67M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $2.47M 10-Q · filed 2026-08-19 | $4.96M 10-Q · filed 2026-08-19 | $7.67M derived: sum of 3 quarters · filed 2026-08-19 | $9.69M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $2.49M 10-Q · filed 2026-05-20 | $5.21M derived: sum of 2 quarters · filed 2026-05-20 | $7.22M derived: sum of 3 quarters · filed 2026-05-20 | $8.74M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $4.72M derived: sum of 2 quarters · filed 2026-04-07 | $6.25M derived: sum of 3 quarters · filed 2026-04-07 | $7.69M 10-K · filed 2026-04-07 | ||||
| 2024-09-30 | $2.01M 10-Q · filed 2025-11-14 | $3.53M derived: sum of 2 quarters · filed 2025-11-14 | $4.98M 10-Q · filed 2025-11-14 | $6.51M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $1.52M 10-Q · filed 2025-08-14 | $2.97M 10-Q · filed 2025-08-14 | $4.50M derived: sum of 3 quarters · filed 2025-08-14 | $5.97M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.44M 10-Q · filed 2025-05-15 | $2.97M derived: sum of 2 quarters · filed 2025-05-15 | $4.45M derived: sum of 3 quarters · filed 2025-05-15 | $6.02M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.00M derived: sum of 2 quarters · filed 2025-03-31 | $4.58M derived: sum of 3 quarters · filed 2025-03-31 | $6.46M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.47M 10-Q · filed 2024-11-13 | $3.04M derived: sum of 2 quarters · filed 2024-11-13 | $4.93M 10-Q · filed 2024-11-13 | $6.68M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $1.57M 10-Q · filed 2024-08-13 | $3.46M 10-Q · filed 2024-08-13 | $5.21M derived: sum of 3 quarters · filed 2024-08-13 | $7.31M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $1.88M 10-Q · filed 2024-05-14 | $3.63M derived: sum of 2 quarters · filed 2024-05-14 | $5.74M derived: sum of 3 quarters · filed 2024-05-14 | $7.88M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.86M derived: sum of 2 quarters · filed 2024-04-01 | $6.00M derived: sum of 3 quarters · filed 2024-04-01 | $8.84M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $2.11M 10-Q · filed 2023-11-14 | $4.25M derived: sum of 2 quarters · filed 2023-11-14 | $7.09M 10-Q · filed 2023-11-14 | $9.39M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $2.14M 10-Q · filed 2023-08-14 | $4.98M 10-Q · filed 2023-08-14 | $7.28M derived: sum of 3 quarters · filed 2023-08-14 | $9.54M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $2.83M 10-Q · filed 2023-05-15 | $5.13M derived: sum of 2 quarters · filed 2023-05-15 | $7.39M derived: sum of 3 quarters · filed 2023-05-15 | $9.59M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $4.56M derived: sum of 2 quarters · filed 2023-03-24 | $6.75M derived: sum of 3 quarters · filed 2023-03-24 | $8.89M 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | $2.26M 10-Q · filed 2022-11-14 | $4.45M derived: sum of 2 quarters · filed 2022-11-14 | $6.60M 10-Q · filed 2022-11-14 | $8.47M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $2.19M 10-Q · filed 2022-08-22 | $4.33M 10-Q · filed 2022-08-22 | $6.21M derived: sum of 3 quarters · filed 2022-08-22 | $7.74M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | $2.14M 10-Q · filed 2022-05-10 | $4.02M derived: sum of 2 quarters · filed 2022-05-10 | $5.55M derived: sum of 3 quarters · filed 2022-05-10 | $7.28M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.41M derived: sum of 2 quarters · filed 2022-03-11 | $5.14M derived: sum of 3 quarters · filed 2022-03-11 | $6.61M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $1.53M 10-Q · filed 2021-11-17 | $3.26M derived: sum of 2 quarters · filed 2021-11-17 | $4.73M 10-Q · filed 2021-11-17 | $6.23M derived: sum of 4 quarters · filed 2021-11-17 | ||||
| 2020-06-30 | $1.73M 10-Q · filed 2021-08-13 | $3.20M 10-Q · filed 2021-08-13 | $4.70M derived: sum of 3 quarters · filed 2021-08-13 | $6.40M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.47M 10-Q · filed 2021-05-17 | $2.97M derived: sum of 2 quarters · filed 2021-05-17 | $4.67M derived: sum of 3 quarters · filed 2021-05-17 | $6.84M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $3.20M derived: sum of 2 quarters · filed 2021-03-31 | $5.37M derived: sum of 3 quarters · filed 2021-03-31 | $6.94M 10-K · filed 2021-03-31 | $6.94M 10-K · filed 2020-04-03 | |||
| 2019-09-30 | $1.70M 10-Q · filed 2020-11-16 | $1.70M 10-Q · filed 2019-11-14 | $3.87M derived: sum of 2 quarters · filed 2020-11-16 | $5.44M 10-Q · filed 2020-11-16 | $5.44M 10-Q · filed 2019-11-14 | $8.15M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $2.17M 10-Q · filed 2020-08-13 | $2.17M 10-Q · filed 2019-08-14 | $3.74M 10-Q · filed 2020-08-13 | $3.74M 10-Q · filed 2019-08-14 | $6.45M derived: sum of 3 quarters · filed 2020-08-13 | $9.17M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $1.56M 10-Q · filed 2020-05-15 | $1.57M 10-Q · filed 2019-05-21 | $4.28M derived: sum of 2 quarters · filed 2020-05-15 | $6.99M derived: sum of 3 quarters · filed 2020-05-15 | $9.68M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $5.43M derived: sum of 2 quarters · filed 2020-04-03 | $8.12M derived: sum of 3 quarters · filed 2020-04-03 | $9.83M 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $2.72M 10-Q · filed 2019-11-14 | $5.41M derived: sum of 2 quarters · filed 2019-11-14 | $7.12M 10-Q · filed 2019-11-14 | $9.26M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $2.69M 10-Q · filed 2019-08-14 | $4.40M 10-Q · filed 2019-08-14 | $6.54M derived: sum of 3 quarters · filed 2019-08-14 | $7.21M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $1.71M 10-Q · filed 2019-05-21 | $3.85M derived: sum of 2 quarters · filed 2019-05-21 | $4.52M derived: sum of 3 quarters · filed 2019-05-21 | $4.67M derived: sum of 4 quarters · filed 2019-05-21 | ||||
| 2017-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | $2.80M derived: sum of 2 quarters · filed 2019-04-10 | $2.96M derived: sum of 3 quarters · filed 2019-04-10 | $3.08M 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | $663.76K 10-Q · filed 2018-11-19 | $821.00K derived: sum of 2 quarters · filed 2018-11-19 | $943.91K 10-Q · filed 2018-11-19 | $1.07M derived: sum of 4 quarters · filed 2018-11-19 | ||||
| 2017-06-30 | $157.23K 10-Q · filed 2018-08-13 | $280.14K 10-Q · filed 2018-08-13 | $410.24K derived: sum of 3 quarters · filed 2018-08-13 | $547.12K derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $122.91K 10-Q · filed 2018-05-15 | $253.01K derived: sum of 2 quarters · filed 2018-05-15 | $389.89K derived: sum of 3 quarters · filed 2018-05-15 | $443.94K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $130.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-09 | $266.98K derived: sum of 2 quarters · filed 2018-04-09 | $321.03K derived: sum of 3 quarters · filed 2018-04-09 | $485.44K 10-K · filed 2018-04-09 | ||||
| 2016-09-30 | $136.88K 10-Q · filed 2017-11-20 | $190.93K derived: sum of 2 quarters · filed 2017-11-20 | $355.35K 10-Q · filed 2017-11-20 | $601.16K derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | $54.05K 10-Q · filed 2017-08-09 | $218.46K 10-Q · filed 2017-08-09 | $464.28K derived: sum of 3 quarters · filed 2017-08-09 | $630.02K derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $164.41K 10-Q/A · filed 2017-06-23 | $410.23K derived: sum of 2 quarters · filed 2017-06-23 | $575.97K derived: sum of 3 quarters · filed 2017-06-23 | $739.20K derived: sum of 4 quarters · filed 2017-06-23 | ||||
| 2015-12-31 | $245.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $411.56K derived: sum of 2 quarters · filed 2017-02-15 | $574.79K derived: sum of 3 quarters · filed 2017-02-15 | $765.09K 10-K · filed 2017-02-15 | ||||
| 2015-09-30 | $165.75K 10-Q · filed 2016-11-14 | $328.97K derived: sum of 2 quarters · filed 2016-11-14 | $519.27K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $163.23K 10-Q · filed 2016-08-15 | $353.53K 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | $190.30K 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |